AZN vs CPHI · P/E 28, $288.38B cap vs rev $4.1M
AstraZeneca PLC (AZN) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the AZN and CPHI stock pages for the full models.
Not investment advice.